These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34232977)

  • 1. Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia.
    Bollard CM
    Blood; 2021 Sep; 138(11):913. PubMed ID: 34232977
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.
    Hossain MA; Bungert J
    Mol Ther; 2017 Mar; 25(3):561-562. PubMed ID: 28190778
    [No Abstract]   [Full Text] [Related]  

  • 3. Tweaking genes with CRISPR or viruses fixes blood disorders.
    Kaiser J
    Science; 2020 Dec; 370(6522):1254-1255. PubMed ID: 33303593
    [No Abstract]   [Full Text] [Related]  

  • 4. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
    Bauer DE; Brendel C; Fitzhugh CD
    Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for sickle cell disease.
    The Lancet Haematology
    Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for sickle cell disease: where we are now?
    Kanter J; Falcon C
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):174-180. PubMed ID: 34889358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promise of gene therapy to treat sickle cell disease.
    Romero Z; DeWitt M; Walters MC
    Expert Opin Biol Ther; 2018 Nov; 18(11):1123-1136. PubMed ID: 30324810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters affecting successful stem cell collections for genetic therapies in sickle cell disease.
    Justus DG; Manis JP
    Transfus Apher Sci; 2021 Feb; 60(1):103059. PubMed ID: 33541761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gates and NIH join forces on HIV and sickle cell diseases.
    Cohen J; Kaiser J
    Science; 2019 Nov; 366(6465):558-559. PubMed ID: 31672872
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in gene therapy for hemophilia: basis, current status, and future perspectives.
    Ohmori T
    Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy: Erasing sickle-cell disease.
    Bourzac K
    Nature; 2017 Sep; 549(7673):S28-S30. PubMed ID: 28953858
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
    Hollister BM; Gatter MC; Abdallah KE; Armsby AJ; Buscetta AJ; Byeon YJJ; Cooper KE; Desine S; Persaud A; Ormond KE; Bonham VL
    CRISPR J; 2019 Dec; 2(6):441-449. PubMed ID: 31742431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Gene Therapy in Hemophilia.
    Hu YF; Fang YH; Lai YR; Feng XQ; Xu SQ
    Curr Med Sci; 2022 Oct; 42(5):925-931. PubMed ID: 36260269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.
    Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G
    Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cas9 Hammer-and Sickle: A Challenge for Genome Editors.
    Urnov FD
    CRISPR J; 2021 Feb; 4(1):6-13. PubMed ID: 33616446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are genetic approaches still needed to cure sickle cell disease?
    Brodsky RA; DeBaun MR
    J Clin Invest; 2020 Jan; 130(1):7-9. PubMed ID: 31738187
    [No Abstract]   [Full Text] [Related]  

  • 18. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
    Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
    Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management issues for collaborative study in hematology. Sickle cell anemia, hemophilia, and ITP.
    Cohen A
    Clin Pediatr (Phila); 1987 Dec; 26(12):615-9. PubMed ID: 3315385
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic-Based Approaches to Inherited Metabolic Liver Diseases.
    Zabaleta N; Hommel M; Salas D; Gonzalez-Aseguinolaza G
    Hum Gene Ther; 2019 Oct; 30(10):1190-1203. PubMed ID: 31347416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.